a plus sales & marketing inc.

535 w. central ave.
monsey, new york 10952

NYS Entity Status
ACTIVE

NYS Filing Date
APRIL 16, 2013

NYS DOS ID#
4389128

County
ROCKLAND

Jurisdiction
NEW YORK

Registered Agent
NONE

NYS Entity Type
DOMESTIC BUSINESS CORPORATION

Name History
2013 - A PLUS SALES & MARKETING INC.









Buffer



submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • AROUND THE WEB

  • Time Inc Taps Schraft To Head Foundry's Content Sales, 'New Yorker' Hires First Newsletter Director
    Thursday Jul 13, 2017

    In a move to expand its native advertising business, Time Inc. has promoted Chris Schraft to president of content sales and agency development of The Foundry, its branded content studio. 'The NewYorker' has hired Dan Oshinsky as its first director of newsletters.

    Source: Media Post: Social Media & Marketing Daily
  • Time Inc. Moves Into Social Video, Targets GenZ And Millennials With 'The Pretty'
    Tuesday Jun 20, 2017

    Eager to capture the attention of 16- to-35-year-old beauty enthusiasts, Time Inc. has launched "The Pretty," a new social video brand. What's notable is the all-video approach that offers how-tos,hacks, product information, and entertainment, plus the plan to target both GenZ -- starting at around age 16 -- in addition to Millennials.

    Source: Media Post: Social Media & Marketing Daily
  • Amazon stopped Whole Foods from seeking a bidding war
    By Reuters - Friday Jul 7, 2017

    Amazon.com Inc told Whole Foods Market Inc it would not engage in a sale process for the U.S. grocer that involved other bidders, a regulatory filing showed on Friday, shedding new light on the $13.7 billion acquisition. The previously undisclosed details on the negotiations show how Amazon used its deep pockets and brand as leverage […]

    Source: VentureBeat
  • Abbvie’s hep C drug pricing threatens Gilead’s dominance
    By Max Nisen - Tuesday Aug 8, 2017

    Pharma already leads the business world in unpredictability, with billions in sales potentially riding on a few points of statistical significance in a clinical trial.[...] even within that context, a series of blockbuster medicines for hepatitis C have made for a roller-coaster ride for companies and investors.AbbVie Inc. last week threw another big curve at this market by pricing its newly FDA-approved drug Mavyret — which might be the most effective hepatitis C medicine approved yet — at a massive discount.Medicines from Johnson & Johnson, Merck & Co. Inc. and Vertex Pharmaceuticals Inc. approved within the past six years, which once booked billions in combined sales, are now essentially non-factors.After offering behind-the-scene discounts to insurance companies, pharmacy benefit managers and other payers, Mavyret’s price is actually not far from Harvoni’s, according to Bloomberg Intelligence.The real headache for Gilead — which already faces steep declines in hepatitis C drug sales because of increasing competition and the fact that many patients have been cured — lies in the fact that not all hepatitis patients or medicines are the same.AbbVie’s new drug can treat all of the major subtypes of hepatitis C. And it can cure the disease in many patients in just eight weeks.

    Source: SFGATE.com: Business and Technology News
  • Email A Distant Fourth In Back-To-School Sales
    Thursday Aug 3, 2017

    It's already August. Brands have only a few weeks to get out their back-to-school sales.

    Source: Media Post: Social Media & Marketing Daily
a plus sales amp marketing inc monsey ny